Cutaneous wound healing: myofibroblastic differentiation and in vitro models
- PMID: 15866829
- DOI: 10.1177/1534734603256155
Cutaneous wound healing: myofibroblastic differentiation and in vitro models
Abstract
Wound healing is an interactive, dynamic 3-phased process. During the formation of granulation tissue, many fibroblastic cells acquire some morphological and biochemical smooth muscle features and are called myofibroblasts. Myofibroblasts participate in both granulation tissue formation and remodeling phases. Excessive scarring, which is a feature of impaired healing, is a serious health problem that may affect the patient's quality of life. The treatment costs of such lesions are high, and often, the results are unsatisfactory. To understand the wound healing process better and to promote improvement in human healing, models are needed that can predict the in vivo situation in humans. In vitro models allow the study of cell behavior in a controlled environment. Such modeling partitions and reduces to small scales behavior perceived in vivo. This article is focused on "fibroblasts". In vitro models to study wound healing, the role of (myo)fibroblasts, and skin reconstruction in tissue replacement and promotion of wound healing are discussed.
Similar articles
-
The role of contractile proteins in wound healing and fibrocontractive diseases.Methods Achiev Exp Pathol. 1979;9:187-206. Methods Achiev Exp Pathol. 1979. PMID: 763158
-
Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-beta isoforms: an in vivo and in vitro study.Wound Repair Regen. 1996 Apr-Jun;4(2):278-87. doi: 10.1046/j.1524-475X.1996.40217.x. Wound Repair Regen. 1996. PMID: 17177825
-
Fibroblast differentiation in wound healing and fibrosis.Int Rev Cytol. 2007;257:143-79. doi: 10.1016/S0074-7696(07)57004-X. Int Rev Cytol. 2007. PMID: 17280897 Review.
-
Impaired cutaneous wound healing with excess granulation tissue formation in TNFalpha-null mice.Arch Dermatol Res. 2009 Aug;301(7):531-7. doi: 10.1007/s00403-009-0969-z. Epub 2009 Jun 20. Arch Dermatol Res. 2009. PMID: 19543902
-
Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.Int J Biochem Cell Biol. 2006 Feb;38(2):135-51. doi: 10.1016/j.biocel.2005.08.021. Epub 2005 Sep 23. Int J Biochem Cell Biol. 2006. PMID: 16257564 Review.
Cited by
-
Antimicrobial activities of silver used as a polymerization catalyst for a wound-healing matrix.Biomaterials. 2006 Aug;27(24):4304-14. doi: 10.1016/j.biomaterials.2006.03.038. Epub 2006 Apr 24. Biomaterials. 2006. PMID: 16635526 Free PMC article.
-
Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy.Pharmaceutics. 2024 Dec 1;16(12):1539. doi: 10.3390/pharmaceutics16121539. Pharmaceutics. 2024. PMID: 39771518 Free PMC article.
-
Anti-inflammatory and protective investigations on the effects of Theranekron® "an alcoholic extract of the Tarantula cubensis" on wound healing of peritoneal in the rat: an in vivo comparative study.Diagn Pathol. 2015 Apr 2;10:19. doi: 10.1186/s13000-015-0252-x. Diagn Pathol. 2015. Retraction in: Diagn Pathol. 2016 Nov 2;11(1):118. doi: 10.1186/s13000-016-0575-2. PMID: 25889956 Free PMC article. Retracted.
-
Fibronectin matrix mimetics promote full-thickness wound repair in diabetic mice.Tissue Eng Part A. 2013 Nov;19(21-22):2517-26. doi: 10.1089/ten.TEA.2013.0024. Epub 2013 Aug 12. Tissue Eng Part A. 2013. PMID: 23808793 Free PMC article.
-
Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure.Am J Pathol. 2010 Jan;176(1):108-21. doi: 10.2353/ajpath.2010.090256. Epub 2009 Dec 3. Am J Pathol. 2010. PMID: 19959814 Free PMC article.
LinkOut - more resources
Full Text Sources